Hypertension Awareness, Treatment, and Control in Mexico: An Opportunistic Medical Student-led Blood Pressure Screening Campaign – A Cross-Sectional Study

Authors

  • José Adrián Yamamoto-Moreno Universidad Autónoma de Baja California, Facultad de Medicina y Psicología, Tijuana, México https://orcid.org/0000-0002-2468-5943
  • Suzzette Anaís Navarro-Rodríguez Universidad de Sonora, Departamento de Medicina y Ciencias de la Salud, Hermosillo, México
  • Samuel Ruiz-Pérez Universidad Autónoma de Baja California, Facultad de Medicina y Psicología, Tijuana, México https://orcid.org/0000-0002-9640-7862
  • Juan Carlos Godínez-Reyes Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Guadalajara, México
  • Marvin Mendoza-Rojo Universidad Autónoma de Chihuahua, Facultad de Medicina y Ciencias Biomédicas, Chihuahua, México

DOI:

https://doi.org/10.5195/ijms.2020.639

Keywords:

Hypertension, Blood pressure, Screening, Mexico

Abstract

Background: Hypertension is still a growing public health problem in Mexico. An estimated 151% increase in the number of individuals with hypertension is expected for 2050 if actions are not taken in the country. The aim of this study is to describe hypertension awareness, treatment, control and its associated factors in participants of an opportunistic medical student-led blood pressure screening campaign in Mexico.

Methods: A cross-sectional study, using convenience sampling was performed, including participants aged 18 years and older from 15 Mexican states. Each participant completed a questionnaire about risk factors and had three BP measurements taken. Hypertension was defined as ?140/90 mmHg. Multiple imputation with linear regression was performed where data was missing.

Results: From a population of 2 545 participants, 623 (24.5%) participants had hypertension. Of those with hypertension, 81.9% had a previous diagnosis of hypertension and only 16.1% were not on medication at the time of screening; 61% were controlled, 121% were uncontrolled patients and 18% were not aware they had hypertension. High marginalization was found to have the biggest proportion of uncontrolled cases (33%), while the number of unaware hypertensives in very low marginalization states doubled the national figure. More than half the participants taking antihypertensive agents were on a single medication, achieving control in almost 8 in 10 patients.

Conclusion: It is important to continue making and supporting awareness raising campaigns in different settings across the country to generate more evidence and lead to better programs for improving hypertension detection in Mexico.

References

McEvoy JW, Daya N, Rahman F, Hoogeveen RC, Blumenthal RS, Shah AM, et al. Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline with Incident Cardiovascular Outcomes. JAMA. 2020;323(4):329–38.

Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019;394(10205):1231–42.

Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6(7):e736–43.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795-808.

Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019; 394(10199):639–51.

Beaney T, Schutte AE, Stegiou GS, Borghi C, Burger D, Charchar F, et al. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension. 2020. [Ahead of print].

Ruilope LM, Chagas AC, Brandao AA, Gómez R, Alcalá JJ, Paris JV, et al. Hypertension in Latin America: Current perspectives on trends and characteristics. Hipertens Riesgo Vasc. 2016;34(1):50–56.

Sudharsann N, Geldsetzer P. Impact of Coming Demographic Changes on the Number of Adults in Need of Care for Hypertension in Brazil, China, India, Indonesia, Mexico, and South Africa A Modeling Study. Hypertension. 2019;73(4):770–76.

Sahoo D, Gosai H, Sahoo U, Harsoda JM. Awareness and Practices of Non-Pharmacological Approaches for Management of Hypertension in a Geriatric Population. Int J Med Students. 2014;2(2):53–55.

Campos I, Hernández L, Pedroza A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento, Ensanut MC 2016. Salud Publ Mex. 2018;60(3):233–43.

Consejo Nacional de Evaluación de la Política de Desarrollo Social. Índice de Rezago Social 2015: Presentación de resultados. [Internet]. CONEVAL; May 2016. [cited June 2020]. Available from: https://www.coneval.org.mx/Medicion/Documents/Indice_Rezago_Social_2015/Nota_Rezago_Social_2015_vf.pdf

Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Midle-, and Low-Income Countries. JAMA. 2013;310(9):959–68.

Ríos-Blancas MJ, Cahuana-Hurtado L, Lamadrid-Figueroa H, Lozano R. Cobertura efectiva del tratamiento de la hipertensión arterial en adultos en México por entidad federativa. Salud Publica Mex. 2017;59:154–64.

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-3104.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines 2017. Hypertension. 2018;71:e13–115.

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberg ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376–1414.

Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzuol F, Palatini P. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. J Hypertens. 1995;13(9):965–70.

Gordon T, Kannel WB. Drinking and Its Relation to Smoking, BP, Blood Lipids, and Uric Acid. Arch Intern Med. 1983;143:1366–74.

Beany T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, et al. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019;40(25):2006–17.

Landi F, Calvani R, Picca A, Tosato M, Martone AM, Ortolani E, et al. Body Mass Index is Strongly Associated with Hypertension: Results from the Longevity Check-Up 7+ Study. Nutrients. 2018;10:1976.

Devaux M, Graf S, Goryakin Y, Cecchini M, Huber H, Colombo F. Obesity Update 2017. [Internet]. The Organisation for Economic Co-operation and Development; 2017. [cited June 2020]. Available from: https://www.oecd.org/els/health-systems/Obesity-Update-2017.pdf

Castilla-Guerra L, Fernandez-Moreno MC. Chronic Management of Hypertension after Stroke: The Role of Ambulatory Blood Pressure Monitoring. J Stroke. 2016;18(1):31–37.

Ohta Y, Tsuchihashi T, Ibayashi S, Matsumura K, Kitazono T, Ooboshi H, et al. Blood Pressure Control in Hypertensive Patients With a History of Stroke. J Stroke Cerebrovasc. 2005;14(6):229–33.

Konstantinou K, Tsioufis C, Koumelli A, Mantzouranis M, Kasiakogis A. Doumas M, et al. Hypertension and patients with acute coronary syndrome: Putting blood pressure levels into perspective. J Clin Hypertens. 2019;21(8):1135–43.

Varshney VP, Harrison T, Szymczakowski M, Grossi M, Jones C. Developing a Protocol for Medical Student-Organized Community-Based Hypertension Screening Programs. Int J Med Students. 2013;1(1):8–11.

Published

2020-12-09

How to Cite

Yamamoto-Moreno, J. A., Navarro-Rodríguez, S. A., Ruiz-Pérez, S., Godínez-Reyes, J. C., & Mendoza-Rojo, M. (2020). Hypertension Awareness, Treatment, and Control in Mexico: An Opportunistic Medical Student-led Blood Pressure Screening Campaign – A Cross-Sectional Study. International Journal of Medical Students, 8(3), 263–272. https://doi.org/10.5195/ijms.2020.639

Issue

Section

Original Article